News | News By Subject | News by Disease News By Date | Search News

Diabetes, Type 1 (insulin dependent) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Agreement Reached After Novo Nordisk A/S (NVO) is Accused of Disguising Salespeople and Dealing Kickbacks     5/2/2017
This Bay Area Biotech is Being Wooed by Drug Giant Novo Nordisk A/S (NVO)     3/10/2017
Alphabet's Verily, Sanofi (SNY) Launch $500 Million Onduo, Joint Venture to Open New HQ in Kendall Square     9/13/2016
Lexicon Pharma (LXRX) Rockets on Late-Stage Diabetes Drug Data     9/12/2016
Pharmaceutical Trade Groups Highlight Research Benefits in New Ad Campaigns     2/25/2016
FDA Clears Eli Lilly (LLY)'s Diabetes Drug Basaglar     12/17/2015
Novo Nordisk A/S (NVO) Finally Bags Diabetes Drug Tresiba U.S. Approval     9/28/2015
Novartis AG (NVS) Launches New Portfolio Of Affordable Medicines for Poor Countries     9/24/2015
Novo Nordisk A/S (NVO)’s Victoza Beats Sanofi (SNY)’s Lixisenatide in Head-to-Head Study, Company Says     9/17/2015
Google (GOOG)'s Life Sciences to Partner with Sanofi (SNY) on Diabetes Therapies and Monitors     9/1/2015
Novo Nordisk A/S (NVO) Pulls the Plug on Expanding Victoza for Type 1 Diabetes     8/27/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Study Shows Novo Nordisk A/S (NVO)'s New Diabetes Drug Tresiba Effective And Safe For Children     9/16/2014

News from Around the Web
FDA Warns of Leg, Foot Amputations With Johnson & Johnson (JNJ)'s Diabetes Med, Invokana     5/17/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Bay Area's Livongo Rakes in $52.5 Million     3/17/2017
Artificial Pancreas Race Intensifies Between These 3 Medtech Firms     11/21/2016
Type 1 Diabetes Linked To Epilepsy Risk, China Medical University Children's Hospital Study     4/1/2016
New Findings Could Boost Type 1 Diabetes Treatment, University of Exeter Study     2/29/2016
Infant Weight Gain Linked To Diabetes Risk, Norwegian Institute Of Public Health Study     12/8/2015
Stuff In Yogurt May Decrease Type 1 Diabetes Risk, University of South Florida     11/12/2015
Kids With Type 1 Diabetes At Risk For Mental Health Problems, Karolinska Institute Reveals     2/19/2015
Novel "Smart" Insulin Can Sense Blood Sugar Levels, University of Utah Study     2/10/2015
Broad Institute Researchers Find Link Between Microbiome, Type 1 Diabetes     2/9/2015
Young Kids With Type 1 Diabetes Have Slower Brain Growth, Nemours Children's Clinic Study     12/22/2014
Popular Blood Pressure Drug May Reverse Type 1 Diabetes, University of Alabama at Birmingham Study     11/12/2014
Gluten-Free Diet Cuts Type 1 Diabetes Risk, University of Copenhagen Study     5/9/2014
Men With Diabetes Have Better Blood Sugar Control Than Women, University of Edinburgh Study     9/24/2013

Press Releases
Lexicon Pharma (LXRX) Reports Additional Positive Data From Pivotal InTandem1 Phase III Study For Sotagliflozin In Patients With Type 1 Diabetes     5/11/2017
Novartis AG (NVS) Turns to This Tiny Virtual Biotech for Help in Defeating Type 1 Diabetes     4/19/2017
GeNeuro Initiates Phase IIa Study With Gnbac1 In Type 1 Diabetes In Australia     4/19/2017
New Test IDs Diabetics Who Are At High Risk Of Kidney Failure, Joslin Diabetes Center Study Reveals     4/19/2017
Diabetes Research Institute Release: New Findings Reinforce Possible Role Of High-Dose Vitamin D And Omega-3 Fatty Acids In Halting Type 1 Diabetes Progression     4/13/2017
Helmsley Charitable Trust And Akston Biosciences Announce Partnership To Advance Novel Technology To Treat Type 1 Diabetes     3/16/2017
ProtoKinetix Inc. (PKTX.OB) Announces Start Of Phase I & Phase II Clinical Trials For The Use Of AAGP PKX-001 Treated Islet Cells In The Treatment Of Type 1 Diabetes     3/9/2017
City of Hope Release: Researchers Study Cure For Type 1 Diabetes In Stem Cell Transplantations     3/8/2017
Merck & Co. (MRK), Pfizer (PFE)'s 4-Year Diabetes Alliance Pays Off With FDA, EMA Filings     3/7/2017
Lexicon Pharma (LXRX) Provides Clinical Pipeline Update And Reports 2016 Fourth Quarter And Full Year Financial Results     3/3/2017
Caladrius Biosciences (CLBS) Awarded $12.2 Million Grant From CIRM In Support Of Phase II Clinical Trial Of CLBS03 To Treat Type 1 Diabetes     2/24/2017
Beyond Type 1 Provides Grant To ViaCyte To Support Research And Development Of Cell Replacement Therapies For Type 1 Diabetes     2/23/2017
Eli Lilly (LLY) Bails Out of Ultra-Rapid Insulin Deal With Adocia     1/27/2017
Glytec LLC Release: Grady Health System Improves Diabetes Care With The Company's eGlycemic Management System     1/26/2017
Caladrius Biosciences (CLBS) Release: Biotech Announces Addition Of Three Clinical Sites, Including UCSF, For The Ongoing Phase 2 Study Of CLBS03 In T1D     1/25/2017